-
Sanofi plans to restructure its organizational structure and establish five global business units
Time of Update: 2015-07-20
Source: 2015-7-20 Sanofi plans to restructure its global business and establish five global business units: General Medicine & emerging markets, specialty nursing, diabetes & cardiovascular, Senauer F
-
Formal proposal? Tyva's official acquisition of mylan this week or $43 billion
Time of Update: 2015-07-07
Source: last July 2015-7, Robert Coury, chairman of mylan, stormed and asked Teva to either make a formal offer or stand aside to continue the marriage of Perrigo It's like a woman pointing at a man's
-
Analysis and Prospect of pharmaceutical market in 2015 (R & D
Time of Update: 2015-06-24
Source: Biovalley 2015-06-24 Gilead triple therapy has become the most valuable R & D project in the world The net present value (NPV) of R & D projects in the pharmaceutical industry is 493 billion U
-
Senior members of yaozhi.com went to China Pharmaceutical University to carry out friendly exchange activities
Time of Update: 2015-06-16
On June 12, Li Tianquan, general manager of the R & D center of yaozhi.com, and Ou Lun, general manager of the marketing center, went to China Pharmaceutical University to carry out friendly exchange
-
All listed pharmaceutical enterprises: how to divide 196 enterprises
Time of Update: 2015-04-24
Source: bioprospecting 2015-4-24 is of great importance to the development of the whole Chinese pharmaceutical industry In recent years, there are several important things: 1 Fierce competition, large
-
Who owns the most? Top 100 express report of main revenue of pharmaceutical industry in 2014
Time of Update: 2015-04-08
Source: from April 7, 2015 to April 7, 2015, the Ministry of industry and information technology released the ranking of industrial enterprises in the pharmaceutical industry in 2014, ranking Enterpri
-
Patent analysis and application to assist new drug research and development of Laimei pharmaceutical
Time of Update: 2015-02-09
What's the status of competitors' patents?
How to avoid and bypass others' existing patents?
-
EU regulators recommend suspending access to Indian drug data
Time of Update: 2015-01-26
Source: DXY 2015-01-26 European drug regulatory agency said on 23 this month that it has proposed to suspend the clinical research of several drugs carried out by GVK Biosciences in Hyderabad, India T
-
Can xiumeile, the first generic drug, still be the "best seller
Time of Update: 2014-12-12
In 2013, Humira's sales reached US $10.6 billion, ranking first among the top 25 best-selling drugs in 2013 Recently, India's imitator, Cadila, announced the launch of exemptia, the world's first imitator of Sumeria in India Cadila plans to set the price of exemptia as one fifth of that of Sumeria As soon as India's pharmaceutical companies sell, any high price will tremble!
-
On the direction of medical reform from the implementation of centralized purchase in public hospitals
Time of Update: 2014-11-15
Source: the guiding opinions on the implementation of centralized drug purchase in public hospitals (2014-11-15) has been circulating for a while All kinds of immortals have carried out omni-direction
-
It is not easy for foreign capital to recruit high-quality generic drugs and sink into the grass-roots level to exchange price for quantity
Time of Update: 2014-09-17
Source: pharmaceutical economic news 2014-09-17: strategies for foreign enterprises to extend drug life cycle and improve product imitation barriers, which can be used for reference by domestic enterp
-
Innovation or will ease the competition of pharmaceutical machinery industry
Time of Update: 2014-04-01
Pharmaceutical machinery and equipment industry is an indispensable support force in the field of medicine In recent years, the development of pharmaceutical machinery industry is very rapid, but the
-
The integration of pharmaceutical M
Time of Update: 2014-02-24
Source: the state owned assets supervision and Administration Commission of the people's Republic of China issued relevant guidance on February 24, 2014, pointing out that the central enterprises shou
-
Cracking down on commercial bribery, keeping high pressure, forcing drug companies to change
Time of Update: 2013-12-25
2013-12-25 source: Recently, GSK announced to adjust its global sales and marketing model and change the remuneration system of medical representatives, which attracted attention GSK China is suspecte
-
Scientific and technological innovation, revitalizing the traditional Chinese medicine Shouxian Guhua 1 million to take a scientific research achievement
Time of Update: 2013-12-23
Recently, the 2013 Zhejiang technology achievement auction ended in Baimahu International Convention and Exhibition Center A total of 478 enterprises rushed to this technology feast, and 174 projects
